Sesen Bio, Inc.
SESN · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $40,000 | $26,544 | $11,236 |
| % Growth | -100% | 50.7% | 136.2% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $40,000 | $26,544 | $11,236 |
| % Margin | – | 100% | 100% | 100% |
| R&D Expenses | $59,673 | $38,594 | $25,312 | $29,191 |
| G&A Expenses | $22,138 | $39,787 | $29,393 | $14,302 |
| SG&A Expenses | $22,138 | $39,787 | $29,393 | $14,302 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $296 | -$60 | $125 |
| Operating Expenses | $81,811 | $78,381 | $54,705 | $43,493 |
| Operating Income | $0 | -$25,909 | -$8,549 | -$21,077 |
| % Margin | – | -64.8% | -32.2% | -187.6% |
| Other Income/Exp. Net | $0 | $2,150 | -$60 | $125 |
| Pre-Tax Income | -$60,477 | -$23,759 | -$8,609 | -$20,952 |
| Tax Expense | $0 | -$3,875 | -$8,273 | $1,445 |
| Net Income | -$60,477 | -$19,884 | -$336 | -$22,397 |
| % Margin | – | -49.7% | -1.3% | -199.3% |
| EPS | -1.46 | -1.99 | -0.037 | -3.79 |
| % Growth | 26.6% | -5,293% | 99% | – |
| EPS Diluted | -1.46 | -1.99 | -0.037 | -3.8 |
| Weighted Avg Shares Out | 41,456 | 9,973 | 9,116 | 5,911 |
| Weighted Avg Shares Out Dil | 41,456 | 9,973 | 9,116 | 5,911 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1,854 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $13 | -$39,139 | -$22,238 |
| EBITDA | $0 | -$50,840 | -$8,549 | -$21,077 |
| % Margin | – | -127.1% | -32.2% | -187.6% |